AIC
IOVA icon

Ameritas Investment Company’s Iovance Biotherapeutics IOVA Stock Holding History

Ameritas Investment Company’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-60
Closed -$1.9K – 1372
2021
Q1 		$1.9K Buy
+60
New +$2.49K ﹤0.01% 1935
2020
Q2 		– Sell
-60
Closed -$2K – 945
2020
Q1 		$2K Buy
+60
New +$1.59K ﹤0.01% 1574
2019
Q4 		– Sell
-60
Closed -$1K – 1159
2019
Q3 		$1K Buy
+60
New +$1.33K ﹤0.01% 1565

Other funds holding IOVA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Ameritas Investment Company's IOVA Position: Q2 2021 in Review

Ameritas Investment Company sold out of Iovance Biotherapeutics (IOVA) in Q2 2021, closing a stake of 60 shares — an estimated $1.9K sold.

Ameritas Investment Company first reported a position in IOVA in Q3 2019 and held it in 3 quarters. The position peaked at $2K in Q1 2020. 233 funds tracked by Wall St. Rank hold IOVA as of Q2 2021.

  • Ameritas Investment Company reported no remaining Iovance Biotherapeutics position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 60 Iovance Biotherapeutics shares in Q2 2021, an estimated $1.9K.
  • Ameritas Investment Company first reported a position in Iovance Biotherapeutics in Q3 2019 and held it in 3 quarters.
  • Ameritas Investment Company's Iovance Biotherapeutics position peaked at $2K in Q1 2020.
  • 233 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.